Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document.

Published on Jul 1, 2010in Pancreas2.92
· DOI :10.1097/MPA.0B013E3181E4D9E5
Suresh T. Chari103
Estimated H-index: 103
(Mayo Clinic),
Guenter Kloeppel2
Estimated H-index: 2
(Mayo Clinic)
+ 3 AuthorsMarkus M. Lerch102
Estimated H-index: 102
(Mayo Clinic)
Abstract Autoimmune pancreatitis (AIP) has been extensively reported from Japan, Europe, and the United States. Whereas the descriptions of AIP from Japan have predominantly been based on the presence of a distinct clinical phenotype, reports from Europe and the United States describe at least 2 histopathologic patterns in patients' condition currently diagnosed as AIP, viz, lymphoplasmacytic sclerosing pancreatitis (LPSP) and idiopathic duct centric pancreatitis (IDCP) or granulocyte epithelial lesion (GEL)-positive pancreatitis. Although the 2 entities share common histopathologic features (periductal lymphoplasmacytic infiltration and peculiar periductal fibrosis), expert pathologists can accurately distinguish them based on other unique histopathologic features. Clinically, the 2 entities have similar clinical presentation (obstructive jaundice/pancreatic mass and a dramatic response to steroids) but differ significantly in their demography, serological characteristics, other organ involvement, and disease relapse. While LPSP is associated with elevation in titers of nonspecific autoantibodies and serum IgG4 levels, IDCP does not have definitive serological autoimmune markers. All experts agreed that the clinical phenotypes associated with LPSP and IDCP should be nosologically distinguished; however, their terminology was debated. Whereas most experts agreed that the entities should be referred to as type 1 and type 2 AIP, respectively, others had concerns regarding use of the term "autoimmune" to describe IDCP.
📖 Papers frequently viewed together
28 Citations
14 Authors (Tooru Shimosegawa, ..., Lizhi Zhang)
959 Citations
2,047 Citations
#1Phil A. Hart (The Ohio State University Wexner Medical Center)H-Index: 29
#2Yoh Zen (Kobe University)H-Index: 87
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 3 authors...
Autoimmune pancreatitis (AIP) is distinct from calcifying and obstructive forms of chronic pancreatitis. Clinically and histologically it has two distinct subsets: (i) lymphoplasmacytic sclerosing pancreatitis or type 1 AIP which appears to be a systemic disease characterised by abundant infiltration of affected organs with immunoglobulin G4 (IgG4)-positive plasma cells and (2) duct-centric or type 2 AIP characterised by granulocyte epithelial lesions in the pancreas without systemic involvement...
293 CitationsSource
#6A. Kanno (Tohoku University)
Objective: To establish an appropriate steroid treatment regimen for autoimmune pancreatitis (AIP). Methods: A retrospective survey of AIP treatment was conducted in 17 centres in Japan. The main outcome measures were rate of remission and relapse. Results: Of 563 patients with AIP, 459 (82%) received steroid treatment. The remission rate of steroid-treated AIP was 98%, which was significantly higher than that of patients without steroid treatment (74%, 77/104; p Conclusions: The major indicatio...
520 CitationsSource
#1Makoto Otsuki (University of Occupational and Environmental Health Japan)H-Index: 35
#2Jae Bock ChungH-Index: 33
Last. Yasuyuki Kihara (University of Occupational and Environmental Health Japan)H-Index: 19
view all 15 authors...
In 2002, the Japan Pancreas Society (JPS) was the first in the world to propose diagnostic criteria for autoimmune pancreatitis (AIP). Since the concept of AIP has changed with the accumulation of AIP cases, the Research Committee of Intractable Pancreatic Diseases (RCIPD) provided by the Ministry of Health, Labour and Welfare of Japan and the JPS issued revised clinical diagnostic criteria of AIP in 2006. The Asan Medical Center of Korea also proposed diagnostic criteria for AIP in 2006. Howeve...
359 CitationsSource
#1Seunghyun Kwon (UOU: University of Ulsan)H-Index: 8
#2Myung-Hwan KimH-Index: 89
Last. Eugene K. ChoiH-Index: 16
view all 3 authors...
Abstract:Autoimmune chronic pancreatitis (AIP) is increasingly being recognized as a worldwide entity. In 2002, the Japan Pancreas Society published diagnostic criteria for AIP. Since then, increased attention toward this relatively new disease entity has enabled more cases of AIP to be correctly di
78 CitationsSource
#1Günter Klöppel (CAU: University of Kiel)H-Index: 108
Chronic pancreatitis is a fibroinflammatory disease of the pancreas. Etiologically, most cases are related to alcohol abuse and smoking. Recently, gene mutations have been identified as the cause of hereditary pancreatitis. Other chronic pancreatitis types that were defined in recent years are autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis) and paraduodenal pancreatitis (‘groove pancreatitis’, ‘cystic dystrophy of heterotopic pancreas’). This review describes and discusses th...
115 CitationsSource
#1Lizhi Zhang (Mayo Clinic)H-Index: 54
#2Kenji Notohara (Okayama University)H-Index: 41
Last. Thomas C. Smyrk (Mayo Clinic)H-Index: 116
view all 5 authors...
Autoimmune pancreatitis typically produces an enlarged pancreas with narrowing of the pancreatic duct, and can mimic carcinoma. Autoimmune pancreatitis usually responds to corticosteroid treatment, making it important to differentiate from pancreatic ductal adenocarcinoma. Affected patients often have an elevated serum IgG4. It has been proposed that increased numbers of IgG4-positive plasma cells in tissue might be a marker for the condition. We investigated the role of IgG4 staining in the dia...
232 CitationsSource
#1Vikram Deshpande (Harvard University)H-Index: 120
#2Sonia L. ChicanoH-Index: 3
Last. Gregory Y. LauwersH-Index: 100
view all 8 authors...
Autoimmune pancreatitis (AIP) is a mass forming inflammatory pancreatobiliary-centric disease. Recent reports of multiorgan inflammatory mass forming lesions with increased numbers of IgG4 positive plasma cells suggest that AIP may have a systemic component. In this study, we explore the systemic na
264 CitationsSource
#1Suresh T. Chari (Mayo Clinic)H-Index: 103
#2Thomas C. Smyrk (Mayo Clinic)H-Index: 116
Last. Michael B. Farnell (Mayo Clinic)H-Index: 84
view all 11 authors...
Background & Aims: The Japan Pancreas Society criteria for diagnosis of autoimmune pancreatitis (AIP) mandate presence of characteristic imaging (diffuse pancreatic enlargement with diffusely irregular, narrow pancreatic duct). AIP has unique histologic features associated with infiltration of tissues of affected organs with abundant IgG4-positive cells. We propose expanded diagnostic criteria for AIP with a cohort of histologically confirmed AIP. Methods: We reviewed the pancreatic imaging find...
770 CitationsSource
#1Kazuichi Okazaki (Kansai Medical University)H-Index: 85
#2Shigeyuki Kawa (Shinshu University)H-Index: 67
Last. Makoto Otsuki (University of Occupational and Environmental Health Japan)H-Index: 9
view all 18 authors...
In 1961, Sarles et al.1 asked the following question regarding the particular cases of pancreatitis with hypergammaglobulinemia: “Chronic inflammatory sclerosis of the pancreas—an autoimmune pancreatic disease?” As similar cases were rarely observed, a relationship between such pancreatitis and autoimmunity was viewed skeptically during the following several decades. In 1992, Toki et al.2 have reported 4 cases with unusual diffuse irregular narrowing of the main pancreatic duct and diffuse enlar...
478 CitationsSource
#1Giuseppe Zamboni (University of Verona)H-Index: 81
#2Jutta Lüttges (CAU: University of Kiel)H-Index: 49
Last. Günter Klöppel (CAU: University of Kiel)H-Index: 108
view all 9 authors...
Background and Aims Autoimmune pancreatitis seems to be a disease with a heterogeneous appearance. Our intention was to establish key diagnostic criteria, define grades of severity and activity, identify features of potential subtypes and evaluate the diagnostic relevance of biopsy specimens.
523 CitationsSource
Cited By176
Ordinary chronic pancreatitis is a well-known risk factor for pancreatic cancer, whereas such an association with autoimmune pancreatitis (AIP) is widely debated. Due to the rarity of the latter disorder, there are few specific clinical and epidemiological studies investigating the relation between AIP and pancreatic cancer, which do not seem to support it. However, these studies are affected by several limitations and, therefore, a link between AIP (and, specifically, type 1 AIP) and pancreatic...
#1Atsushi Kanno (Jichi Medical University)H-Index: 18
#2Tetsurou Miwata (Jichi Medical University)H-Index: 1
Last. Noriyoshi Fukushima (Jichi Medical University)H-Index: 51
view all 12 authors...
Autoimmune pancreatitis (AIP), which is characterized by pancreatic enlargement and irregular narrowing of the main pancreatic duct, is difficult to differentiate from malignancy. The irregular narrowing of the pancreatic duct, which can be detected via endoscopic retrograde cholangiopancreatography, is a characteristic feature of AIP; however, distinguishing between localized AIP and pancreatic cancer based on pancreatic duct imaging is difficult. This study overviews the efficacy of endoscopic...
#1Masataka Yokode (Kyoto University)H-Index: 2
#2Masahiro Shiokawa (Kyoto University)H-Index: 13
Last. Yuzo Kodama (Kobe University)H-Index: 35
view all 3 authors...
Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potential diagnostic biomarkers for AIP. Many investigations have been conducted, but no specific biomarkers for AIP are identified. Therefore, further studies are required to identify accurate diagnostic b...
1 CitationsSource
#1Annarosa Floreani (UNIPD: University of Padua)H-Index: 59
#2Kazuichi Okazaki (Kansai Medical University)H-Index: 85
Last. M. Eric Gershwin (UC Davis: University of California, Davis)H-Index: 139
view all 4 authors...
IgG4-related disease (IgG4-RD) represents an immune-mediated fibroinflammatory condition with peculiar histopathologic changes that can affect various organs. In 2012 its unified nomenclature was published, which allows to abandon other synonymous names. Up to now, only little is known about its epidemiology around the world. However, although it is generally considered a rare condition, the number of patients with IgG4-RD is increasing enormously. Likewise, the annual number of publications on ...
4 CitationsSource
#1A. Kanno (Jichi Medical University)
Autoimmune pancreatitis (AIP) is characterized by enlargement of the pancreas and irregular narrowing of the main pancreatic duct. It is often associated with IgG4-related sclerosing cholangitis (IgG4-SC), in which the bile duct narrows. Although characteristic irregular narrowing of the pancreatic duct caused by endoscopic retrograde cholangiopancreatography is noted in AIP, it is difficult to differentiate between localized AIP and pancreatic carcinoma based on imaging of the pancreatic duct. ...
3 CitationsSource
We report the case of a 60-year-old woman, presenting with painless obstructive jaundice of unknown etiology, who was finally found to suffer from type I autoimmune pancreatitis (AIP). This case emphasizes AIP as a rare cause in the differential diagnosis of obstructive jaundice and the role of endoscopic ultrasound (EUS) in final diagnosis, which is difficult to establish. According to diagnostic criteria, we combined the results from serologic, imaging and histological features (specifically l...
PURPOSE OF REVIEW Type 2 autoimmune pancreatitis (AIP) is a rare inflammatory disease of the pancreas. Very few data have been published on this particular subtype, which differs from the 'classical' IgG4-related type 1 AIP in terms of pathological features, epidemiology and risk of relapse. The aim of the current review is to summarize the available literature, suggesting a diagnostic and therapeutic approach to this disease. RECENT FINDINGS Based on the International Consensus Diagnostic Crite...
2 CitationsSource
#1Mario Pelaez-Luna (UNAM: National Autonomous University of Mexico)H-Index: 17
Last. L.F. Uscanga-DomínguezH-Index: 7
view all 4 authors...
Autoimmune pancreatitis has received considerable attention, especially due to the marked effect of corticosteroid therapy on its clinical course. Knowledge, especially regarding type 1 autoimmune pancreatitis, has significantly increased over the last decades, and despite significant differences in pathophysiology and outcomes, both type 1 and 2 autoimmune pancreatitis are still considered different types of the same disease. Some have proposed a different nomenclature reflecting these differen...
1 CitationsSource
#1Marco LanzillottaH-Index: 1
#2Olof Vinge-Holmquist (Ahus: Akershus University Hospital)H-Index: 1
Last. Jonas Rosendahl (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 9
view all 8 authors...
Introduction: Treatment of autoimmune pancreatitis (AIP) is based solely on consensus and has yet to become standardized. Consequently, therapeutic regimens vary greatly between countries and centres, and largely depend on the experience of the physician. At this moment, the optimal regimen for inducing disease remission and preventing relapse is unknown. Objectives: The primary objective of this study is to describe current treatment regimens used in Europe, and to compare their effectiveness i...
5 CitationsSource
#1Akira Satou (Aichi Medical University)H-Index: 8
#2Kenji NotoharaH-Index: 41
Last. Yasuharu Sato (RMIT: RMIT University)H-Index: 32
view all 7 authors...
IgG4-related disease (RD) is a relatively new entity, which was first proposed in 2001. Since then, clinical and pathological characteristics of the disease have been investigated. As IgG4-RD has been studied extensively, the diagnostic criteria for IgG4-RD of each organ and the comprehensive diagnostic criteria for IgG4-RD have also been developed. However, one of the biggest challenges in the field is distinguishing between IgG4-RD and mimickers, which show overlapping features with IgG4-RD. I...
5 CitationsSource